Varelas, Xaralabos
Boston University
7 papers on CoChatORCID 0000-0002-2882-4541
Most cited papers
- Verified
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology
Hippo pathway signaling and YAP/TAZInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cited by 874
- Verified
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery
Hippo pathway signaling and YAP/TAZTGF-β signaling in diseases
Cited by 860
- Verified
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development
Hippo pathway signaling and YAP/TAZMicrotubule and mitosis dynamics
Cited by 665
- Verified
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine
Systemic Sclerosis and Related DiseasesCell death mechanisms and regulation
Cited by 246
- Verified
The Hippo Pathway Effectors TAZ/YAP Regulate Dicer Expression and MicroRNA Biogenesis through Let-7
Chaulk, S. G., Lattanzi, V. J., Hiemer, S. E., Fahlman, R. P., & Varelas, X. (2014) · Journal of Biological Chemistry
Hippo pathway signaling and YAP/TAZMicroRNA in disease regulation
Cited by 101
- Verified
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression
Jones, D. L., Haak, A. J., Caporarello, N., Choi, K. M., Ye, Z., Yan, H., Varelas, X., Ordog, T., Ligresti, G., & Tschumperlin, D. J. (2019) · Journal of Cell Science
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisHistone Deacetylase Inhibitors Research
Cited by 77
- Verified
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Haak, A., Kostallari, E., Sicard, D., Ligresti, G., Choi, K. M., Caporarello, N., Jones, D., Tan, Q., Meridew, J., Diaz Espinosa, A., et al. (2019) · Mechanisms of lung injury and repair
Hippo pathway signaling and YAP/TAZInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free